Compare FSBW & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSBW | AMRN |
|---|---|---|
| Founded | 1936 | 1989 |
| Country | United States | Ireland |
| Employees | 537 | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.4M | 304.3M |
| IPO Year | 2011 | 1998 |
| Metric | FSBW | AMRN |
|---|---|---|
| Price | $40.14 | $14.07 |
| Analyst Decision | Hold | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $46.00 | $12.00 |
| AVG Volume (30 Days) | 13.0K | ★ 78.1K |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ 4.29 | N/A |
| Revenue | $4,612,000.00 | ★ $181,104,000.00 |
| Revenue This Year | $14.94 | N/A |
| Revenue Next Year | $10.47 | $1.26 |
| P/E Ratio | $9.46 | ★ N/A |
| Revenue Growth | ★ 44.80 | 39.22 |
| 52 Week Low | $36.72 | $9.44 |
| 52 Week High | $44.22 | $20.90 |
| Indicator | FSBW | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 44.48 |
| Support Level | $39.28 | $13.69 |
| Resistance Level | $40.97 | $14.84 |
| Average True Range (ATR) | 0.80 | 0.72 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 22.60 | 52.23 |
FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.